Drawing for CARRY LIFE

USPTO serial 90318443

CARRY LIFE

Reviewed by CopyMark Law Group

Reg. 6689100Status 700Registered
Filing date
Status date
Registration date
Apr 5, 2022
Examiner
RADEMACHER, APRIL LUEDERS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CARRY LIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP8110 GATEHOUSE ROAD, SUITE 100 EASTFALLS CHURCH, VA 22042UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Cachets containing powder for medical purposes namely, any one of glucose powder, potassium powder, magnesium powder, calcium powder, bicarbonate powder or combinations thereof; Antiseptics; Pouches containing powder for medical purposes namely, any one of glucose powder, potassium powder, magnesium powder, calcium powder, bicarbonate powder or combinations thereof; Trays containing powder for medical purposes, namely, anyone of glucose powder, potassium powder, magnesium powder, calcium powder, bicarbonate powder or combinations thereof; Demineralized water for medical purposes; Bactericides; Disinfectants; Dextrins for pharmaceutical use; Diagnostic preparations for medical or veterinary purposes; Dietetic beverages adapted for medical purposes; Dietetic food preparations adapted for medical use; Pharmaceutical preparations for the treatment of kidney diseases; Combinations of calcium salts for pharmaceutical use; Gauze for dressings; Sanitary preparations for medical purposes; Potassium salts for medical purposes; Capsules for medicines sold empty; Chemical preparations for pharmaceutical purposes namely, for treating kidney diseases; Chemical preparations for medical purposes for treating kidney diseases; Medicated compresses for use as dressings; Dialysis infusions for medical use; Dressings, medical; Bicarbonate of soda for pharmaceutical purposes; Nutritional supplements; Adhesive plasters for medical purposes; Powders for medical purposes namely, any one of glucose powder, sodium powder, potassium powder, magnesium powder, calcium powder, bicarbonate powder or combinations thereof; Salts for medical purposes namely, any one of glucose, sodium salt, potassium salt, magnesium salt, calcium salt, bicarbonate or combinations thereof; Powder pouches for medical purposes, namely, any one of glucose powder, sodium powder, potassium powder, magnesium powder, calcium powder, bicarbonate powder or combinations thereofACTIVE—
010Apparatus for blood analysis for medical use; Appliances for washing body cavities; Apparatus for blood analysis for medical uses; Apparatus for cleansing blood during dialysis procedures; Boxes adapted for medical waste products; Containers especially made for medical waste; Blood testing apparatus; Dialyzers for treatment of blood; Dialysis machines for medical use; Dialysis membranes for treatment of blood; Drainage tubes for medical use; Electrodes for medical use; Injection syringes; Cannulae; Catheters; Catheters incorporating filters; Surgical apparatus and instruments; Surgical staples; Medical infusion pumps; Medical syringe needles, namely, hypodermic needles; Catheters for medical use; Probes for medical purposes; Reversed osmosis membranes for medical use for producing water for dialysis; Furniture adapted for medical treatment purposes; Hypodermic needles; Hose systems for peritoneal dialysis comprised of at least one of medical tube connectors, plastic medical tubing for administering dialysis solution, containers for solutions used for the treatment of renal insufficiency, namely, bags, pouches, for concentrates and solutions in solid or liquid form for medical use , and dialysis pump component parts; Probes for medical purposes; Hypodermic needles for use in renal dialysisACTIVE—
044Conducting of medical examinations; Residential medical treatment services; Medical treatment services of organ diseases, for example kidney diseases; Medical clinic services; Medical consultations; Residential medical advice services; Medical counseling; Medical services for the treatment of conditions of the human body namely, treatment of organ diseases, for example kidney diseases; Medical services for the diagnosis of conditions of the human body, namely, treatment of organ diseases, for example kidney diseases; Telemedicine services; Medical services, namely, treatment of organ diseases, for example kidney diseases; Medical evaluation services of treatment of organ diseases, for example kidney diseases; Medical care; Advisory services relating to medical problems; Advisory services relating to medical services; Advice relating to the medical needs of elderly people; Advisory services relating to medical instruments; Services for the preparation of medical reports, namely, providing medical information to patients or medical professionals in the form of reports in the field of organ diseases, for example kidney diseases; Leasing of equipped medical facilities that medical professionals can use on an as-needed basis; Provision of medical services; Compilation of medical reports namely, providing medical information to patients or medical professionals in the form of reports in the field of organ diseases, for example kidney diseases; Issuing of medical reports namely, providing medical information to patients or medical professionals in the form of reports in the field of organ diseases, for example kidney diseases; Medical equipment rental; Hiring of medical instruments, namely, Rental of medical apparatus and instruments; Medical equipment rental; Arranging of accommodation in rest homesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Apr 5, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 23, 2022ISPOWITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST—
Feb 17, 2022D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jan 18, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 18, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 23, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 23, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 23, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 7, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 9, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2021DOCKASSIGNED TO EXAMINER—
Jan 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance